G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity
Authors
Keywords
Glucose-6-phosphate dehydrogenase, Glucose-6-phosphate dehydrogenase deficiency, Glioma, Prognostication, Chemosensitivity
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1007/s11060-018-2911-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D
- (2017) Jakub Chwastek et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway
- (2017) Xin Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
- (2017) Sophie E. M. Veldhuijzen van Zanten et al. JOURNAL OF NEURO-ONCOLOGY
- Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer
- (2017) H-Q Ju et al. ONCOGENE
- Microbiome, inflammation and colorectal cancer
- (2017) Ju Chen et al. SEMINARS IN IMMUNOLOGY
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Cells redox environment modulates BRCA1 expression and DNA homologous recombination repair
- (2016) Aaron Wilson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation Study
- (2016) Michelle M. Kim et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
- (2016) Jeffrey J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia
- (2016) Maria P. Dore et al. MEDICINE
- The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer
- (2016) Nataliya V. Savina et al. Oxidative Medicine and Cellular Longevity
- Risk of Nephrotic Syndrome following Enteroviral Infection in Children: A Nationwide Retrospective Cohort Study
- (2016) Jiun-Nong Lin et al. PLoS One
- Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis
- (2016) Zhen Yang et al. Science Translational Medicine
- Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma
- (2016) F Ahmad et al. Cell Death & Disease
- Prognostic value and their clinical implication of 89-gene signature in glioma
- (2016) Muhammad Shahid et al. Oncotarget
- Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas
- (2015) Zhi-Liang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
- (2015) Yazmín Odia et al. JOURNAL OF NEURO-ONCOLOGY
- Risk of leukaemia in children infected with enterovirus: a nationwide, retrospective, population-based, Taiwanese-registry, cohort study
- (2015) Jiun-Nong Lin et al. LANCET ONCOLOGY
- Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis
- (2015) Zhipeng Wang et al. Scientific Reports
- Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
- (2014) Fred Fack et al. ACTA NEUROPATHOLOGICA
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer
- (2014) Chunhua Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- Regulation of the pentose phosphate pathway in cancer
- (2014) Peng Jiang et al. Protein & Cell
- Brain Glucose-6-phosphate Dehydrogenase Protects against Endogenous Oxidative DNA Damage and Neurodegeneration in Aged Mice
- (2013) Winnie Jeng et al. ACS Chemical Neuroscience
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Phospho-ΔNp63α/SREBF1 protein interactions: Bridging cell metabolism and cisplatin chemoresistance
- (2012) Yiping Huang et al. CELL CYCLE
- Glucose-6-phosphate dehydrogenase, NADPH, and cell survival
- (2012) Robert C. Stanton IUBMB LIFE
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines
- (2012) Anelisa Ramão et al. Proteome Science
- Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas
- (2009) Kaisorn L. Chaichana et al. JOURNAL OF NEUROSURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now